Investigational Site Number : 3920003

Kyoto 606-8507

1 studies enrolling now · 6 studies all time

What they study most

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP), Dermatitis Atopic, Prurigo Nodularis

Studies at this site

• A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials — Enrolling by invitation
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2) — Completed
• A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids — Completed
• Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study — Running, not enrolling
• Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps — Completed